HUNAN ER-KANG PHARMACEUTICAL CO.,LTD. (Stock#300267), founded in October 2003, boasts the largest leading enterprise in pharmaceutical excipient industry, as well as one of the few enterprises with Drug Registration Approvals for both API and finished drug of sulbenicillin sodium. Up to date, it owns 43 API products, 120 pharmaceutical excipients and 148 Drug Approvals for finished drug products, forging a new development configuration that focuses on the three key products of API, finished drugs, and pharmaceutical excipients. ER-KANG was listed in Shenzhen Stock Exchange on Sep. 27th, 2011, being the only listed company in the industry, which has won a series of honorary titles like "2013 Best Potential GEM Listed Corporation", "2013 Most Influential Top 100 Pharmaceutical Enterprises in China ", and “The Listed Company with Best Investment in 2014 ", etc.
Adhering to the policy of "Drug Safety Above Everything ", ER-KANG consistently takes product quality as its lifeline and introduces GMP standards into the production of pharmaceutical excipients for the first time. It now owns multiple state-of-the-art pharmaceutical production lines, internationally advanced drug test devices, and a top-class R & D center with a professional team who have involved in the preparation and revision of over 300 China pharmaceutical excipients standards. ER-KANG is recognized as "National Torch Plan Key High-Tech Enterprise" and the supporting unit of China’s first “State-Level R&D” by National Ministry of Science and Technology
ER-KANG ’s business covers 30 local provinces and autonomous regions, Southeast Asia, Europe, and the North America, with 15 regional offices /distribution centers nationwide and 14 subsidiaries/sub-subsidiaries, namely, Hunan Xiang Yi Kang Pharmaceutical Co., Ltd. (a wholly owned), Nanning Gui Zhilong Pharmaceutical Excipient Co. Ltd. (wholly owned), Hunan Pharmaceutical Excipient Engineering Technology Research Center Co Ltd, Hunan Xiang Li Lai Chemical Co. Ltd. (wholly owned), Hunan ER-Kang (Hongkong) Co., Ltd. (wholly owned), Hunan ER-Kang (Cambodia) Investment Company Limited (wholly owned), Guangdong Yue-Er-Kang Pharmaceutical Co., Ltd. (fully owned), Zhongshan Capsule Starch Material Starch Technology Ltd, Hunan Tongtai Capsule Co., limited, Hunan Kang Zhengyang Pharmaceutical Capsule Co. Ltd. (wholly owned), Hunan Er-Kang Beishang Gelatin Co. Ltd. (wholly owned), Hunan Dongting Citric Acid Chemical Co., Limited, and Wang Kang Biochemical Co. Ltd. (wholly owned)
The company has successfully broken through the technical bottleneck of the new-type high-end starch capsules, and, through a series of optimal integration of domestic and international resources, established a complete industrial chain from upstream raw material to production and end-user market, becoming the world's first cassava starch manufacturer. The company is now registered with FDA and filed the DMF of starch capsule and obtained multiple certificates like Halal by IFANCA, Halal by MUI Indonesia, and Kosher by KOF-K, etc. To further extends the industrial chain, ER-KANG has developed a new product line of trioctylcitrate as a new-type pharmaceutical excipients, forming a new strategic development configuration featured in three key businesses of traditional pharmaceutical excipient, innovative starch capsule, and new product line of trioctylcitrate as pharmaceutical excipients
In the future,ER-KANG will be dedicated to the rejuvenation of national pharmaceutical excipient industry, setup a strong foothold in China, and extend its reach worldwide through continuous innovation. The company is willing to join hands with its counterparts and investors on the base of win-win principle.

Hunan Er-Kang XiangYao Pharmaceutical Company, the subsidiary of HUNAN ER-KANG PHARMACEUTICAL CO.,LTD. is located at the picturesque Liuyang Economic and Technological Development Zone, where logistics network is highly developed.

XiangYao Pharmaceutical is a high-tech pharmaceutical enterprise with registered capital of 64,728,800 RMB. Dedicated to production and distribution, the company owns 148 registered drug products, being the first sulbenicillin sodium manufacturer in China, as well as the only one with approvals for all the three specifications (1g, 2g, 4g) of sulbenicillin sodium, of which, the 4g is exclusive to the company. By 2013, XiangYao has been GMP certified (2010 new version GMP)
At present, the company's flagship products are compound liquorice tablets and methyl benzyl amoxicillin sodium injection, of which, the former is a mucosal protective antitussive with minimal side-effects. It is a prescription drug preferred by majority of patients, while the latter is a new generation of broad-spectrum semi-synthetic penicillin. This essential new prescription drug was launched into the drug market of Hunan province in 2015.

Hunan Xiang Yi Kang Pharmaceutical Co., Ltd., located at the area of Dong Tong lake of Yi Yang City, is a subsidiary wholly owned by HUNAN ER-KANG PHARMACEUTICAL CO.,LTD. though acquisition. All the workshops in the plant are designed and constructed in strict accordance with GMP requirements, and the company now owns advanced excipient workshops, testing center, warehouses and other related facilities, all of which were GMP certified in 2013.
The company's main products include: 1, APIs; 2, pharmaceutical excipient; 3, chemicals (except for hazard chemicals); 4, pharmaceutical intermediates.
In 2014, Xiang Yi Kang Pharmaceutical passed Hunan province "High-Tech Enterprise" identification review, and has won such honorary titles as “Hunan Famous Trade Mark”, “Taxpayer with A-Class Credit " and "Hunan AAA Credit Rating Enterprise in Product Quality ".
We will faithfully provide quality product and service to our customers with the belief in our cooperate culture "Harmony, Loyalty, Diligence, Performance",

Hunan Er-Kang (Cambodia) Investment Co., Ltd. (“Er-Kang Cambodia” for short) was established in Kingdom of Cambodia in 2013, which marked ER-KANG’s engagement in the sector of pharm-grade cassava starch.Wholly funded by HUNAN ER-KANG PHARMACEUTICAL CO.,LTD. , Er-Kang Cambodia, as the executor of this pharma-grade cassava starch project (annual output 180,000 tons) , is specialized in the R&D of the products related to pharm-grade cassava starch and citric acid.

Adhering to the business philosophy "Prospect Future Lies in Professionalism; Great Success Attributes to Quality ", as well as to the corporate mission “Drug Safety Above Everything” and the corporate policy "Harmony, Loyalty, Diligence, Performance", Er-Kang Cambodia is determined to channel its ambition in the field of pharmaceutical grade cassava, in an attempt to lay a solid foundation for the strategic development of the three key business segments, namely, traditional pharmaceutical excipient, revolutionary starch capsules, and trioctyl citrate----the new-type pharmaceutical excipient.

Hunan Pharmaceutical Excipient Engineering Technology Center Co., Ltd. is a high-tech enterprise specialized in the test and R&D of pharmaceutical excipients, the preparation of reference substance of foods and drugs, natural extract isolation&identification, and chemical compounds syntheses, etc. The company well integrates the functions of R&D, production and distribution of reference substance.
Currently, the company received China Metrology Accreditation (CMA). Owing a scientific team led by senior experts in reference substance R&D and equipped with various types of separation, detection, and preparation equipment, the company is capable of providing high-quality RS as well as the services of R&D, separation, identification and customized synthesis of reference substance to universities, research bodies, enterprises, and institutions.
Since its establishment, the company has won trust and praise from the clients home and abroad for its continuous adherence to customer-oriented business philosophy, and thus created a stable and long-term business relationships with them. In the Future, we will continue to provide outstanding service and products to our clients by constantly enforcing strict quality management system and stable product quality.

Hunan Er-Kang BeiShan Gelatin limited is a modern gelatin manufacturer based in Xiangying (to the south of Yueyang city), which, funded by ER-KANG , was established right after Er-Kang’s successful acquisition of Changsha Beishan Gelatin limited (member of Chinese Gelatin association) in 2014.

Following Er-Kang’s corporate mission “Drug Safety Above Everything”, Beishan Gelatin is committed to providing safe and quality product to its clients by strict accordance with the "Chinese Pharmacopoeia" standards and GMP requirements in the whole process from raw materials to final products. Advanced technology, comprehensive quality management system, and sophisticated testing equipment forge the super quality of Baishan Gelatin products. BeiShan major product line: 1.Pharmaceutical grade gelatin, 2.Food grade gelatin. The edible gelatin by BeiShan Gelatin, as an ideal protein source rich in amino acids, is a good quality food additives widely used in the food industry.

Located at JiangNan district of Nanning City, GuangXi province, Nanning GuiZhiLong Pharmaceutical (registered capital 30 billion RMB),a subsidiary of HUNAN ER-KANG PHARMACEUTICAL CO.,LTD. , is specialized in medicinal sucrose development and production.
To ensure product quality, the company upgrades to most advanced production and testing equipment and technology. All its workshops are designed and constructed in strict accordance with the GMP requirements and equipped with domestically advanced facilities; The production, as well as the quality inspection process also strictly follows GMP (2010 version) requirements.
Adhering to ER-KANG’s business philosophy “Prospect Future Lies in Professionalism; Great Success Attributes to Quality”, GuiZhiLong is committed to shouldering the corporate mission “Drug Safety Above Everything” and joining hands with its clients home and abroad to create a bright future !